Immuron Limited American Depositary Shares (IMRN)

About IMRN

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

7

Website

www.immuron.com.au

Fundamentals

1-day range

$1.03$1.14

Market cap

$8.88M

P/E (trailing)

—

P/E (forward)

-110.00

EPS (trailing)

$-0.53

Dividend yield

—

Beta

0.51

Avg. volume

241.1K

Immuron Limited American Depositary Shares Competitors

Chosen by industry and closest market cap.

• IMRN

  Immuron Limited American Depositary Shares

  $1.15

  ▼ 1.29%
  Market cap $8.88MP/E —
  $0.677$2.39
• LEXX

  Lexaria Bioscience Corp. Common Stock

  $10.35

  ▼ 11.39%
  Market cap $8.82MP/E —
  $4.21$23.25
• XCUR

  Exicure Inc. Common Stock

  $1.34

  ▼ 5.32%
  Market cap $8.60MP/E —
• QNRX

  Quoin Pharmaceuticals Ltd. American Depositary Shares

  $6.13

  ▲ 18.91%
  Market cap $9.18MP/E —
  $3.25$41.8
• GDTC

  CytoMed Therapeutics Limited Ordinary Shares

  $0.92

  ▼ 4.17%
  Market cap $9.50MP/E —
  $0.6801$3.68
• SNGX

  Soligenix Inc. Common Stock

  $0.38

  ▲ 0.00%
  Market cap $8.24MP/E —
  $0.28$3.22
• LSTA

  Lisata Therapeutics Inc. Common Stock

  $1.73

  ▼ 4.95%
  Market cap $9.74MP/E —

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

84.9K

Total value held

$65.7K

Institutional holders

7